Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
  1. EFFECT Other Notice of Effectiveness
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. UPLOAD Other SEC-generated Letter
  4. DEFA14A Proxy Proxy Materials
  5. DEF 14A Proxy Proxy Statement
  6. S-3 Offering Registration Statement
  7. 8-K Event Executive or director change
  8. 4 Insider Changes in Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 4 Insider Changes in Ownership
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations
  13. 4 Insider Changes in Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 8-K Event Executive or director change
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 28 of 33 · 660 filings